Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST‐elevation myocardial infarction treated with primary percutaneous coronary intervention
暂无分享,去创建一个
D. Atar | D. Erlinge | S. Halvorsen | H. Arheden | P. Clemmensen | H. Engblom | A. Larsen | A. Stensjøen | M. Sejersten Ripa | T. S. Hall | A. Hommerstad
[1] D. Atar,et al. Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon , 2019, Cardiovascular Drugs and Therapy.
[2] Jeroen J. Bax,et al. Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials , 2019, Journal of the American College of Cardiology.
[3] E. Ohman,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials , 2017, European heart journal.
[4] D. Atar,et al. Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy. , 2017, Journal of electrocardiology.
[5] Einar Heiberg,et al. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. , 2015, European heart journal.
[6] Daniel C. Lee,et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. , 2014, JACC. Cardiovascular imaging.
[7] G. Schuler,et al. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction , 2014, Heart.
[8] L. Bang,et al. A Novel Prehospital Electrocardiogram Score Predicts Myocardial Salvage in Patients with ST-Segment Elevation Myocardial Infarction Evaluated by Cardiac Magnetic Resonance , 2013, Cardiology.
[9] G. Schuler,et al. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. , 2013, Journal of the American College of Cardiology.
[10] D. Atar,et al. Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction , 2012 .
[11] J. McCrohon,et al. Dynamic Changes in ST Segment Resolution After Myocardial Infarction and the Association with Microvascular Injury on Cardiac Magnetic Resonance Imaging. , 2011, Heart, lung & circulation.
[12] D. Atar,et al. Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. , 2010, The American journal of cardiology.
[13] P. Armstrong,et al. ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial , 2008, Circulation.
[14] Y. Kim,et al. Correlation of serial cardiac magnetic resonance imaging parameters with early resolution of ST-segment elevation after primary percutaneous coronary intervention. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[15] P. Algra,et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. , 2008, Journal of the American College of Cardiology.
[16] Einar Heiberg,et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. , 2008, Radiology.
[17] M. Josephson,et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. , 2004, Journal of the American College of Cardiology.
[18] C. Vrints,et al. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. , 1999, Circulation.
[19] Felix Zijlstra,et al. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction , 1997, The Lancet.
[20] K Wegscheider,et al. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. , 1995, Journal of the American College of Cardiology.